— Know what they know.
Not Investment Advice
Also trades as: SNN (NYSE) · $vol 47M · SN.L (LSE) · $vol 43M

SNNUF OTC

Smith & Nephew plc
1W: -0.8% 1M: -2.6% 3M: -16.1% YTD: -19.9% 1Y: -22.0% 3Y: +24.6% 5Y: -13.5%
$13.22
+0.00 (+0.00%)
Pre-Market: $14.73 (+1.51, +11.46%)
Weekly Expected Move ±7.7%
$11 $12 $14 $15 $16
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $11.1B mcap · 818M float · 0.0001% daily turnover · Short 99% of daily vol
Credit Risk of going bust: lower than 72% of companies Debt: 22.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.26 (down 98%), Smith & Nephew plc would be worth roughly what it owes.
Total debt $3.79B against a stock market value of $12.72B.
Distance to default 7.89 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.05B (short-term plus half of long-term), stock volatility 29.0%; Altman Z'' 4.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$6.3B +8.5% ▲
5Y CAGR: +6.7%
Gross Profit
$4.3B +5.9% ▲
5Y CAGR: +6.3%
Operating Income
$1.0B +56.1% ▲
5Y CAGR: +28.3%
Net Income
$639M +55.1% ▲
5Y CAGR: +7.4%
EPS (Diluted)
$0.73 +55.3% ▲
5Y CAGR: +7.4%
EBITDA
$1.6B +31.9% ▲
5Y CAGR: +11.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$5.2B$5.2B$5.5B$5.8B$6.3B
YoY Growth+14.3%+0.1%+6.4%+4.7%+8.5%
Cost of Revenue$1.5B$1.5B$1.7B$1.8B$2.0B
Gross Profit$3.7B$3.7B$3.8B$4.0B$4.3B
Gross Margin70.4%70.5%68.8%69.6%68.0%
R&D Expenses$356M$345M$306M$289M$303M
SG&A Expenses$2.4B$2.4B$2.6B$2.7B$3.0B
Operating Expenses$2.6B$2.6B$3.4B$3.4B$3.3B
Operating Income$593M$450M$425M$657M$1.0B
Operating Margin11.4%8.6%7.7%11.3%16.3%
Interest Expense$79M$79M$139M$147M$159M
Income Before Tax$586M$235M$290M$498M$796M
Tax Expense$62M$12M$27M$86M$157M
Net Income$524M$223M$263M$412M$639M
Net Margin10.1%4.3%4.7%7.1%10.1%
EPS (Diluted)$0.59$0.26$0.30$0.47$0.73
EBITDA$1.2B$986M$956M$1.2B$1.6B
Shares Outstanding878M873M873M876M873M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms